CA2429898A1 - Dispositifs et procedes servant a lutter contre le cholesterol - Google Patents
Dispositifs et procedes servant a lutter contre le cholesterol Download PDFInfo
- Publication number
- CA2429898A1 CA2429898A1 CA002429898A CA2429898A CA2429898A1 CA 2429898 A1 CA2429898 A1 CA 2429898A1 CA 002429898 A CA002429898 A CA 002429898A CA 2429898 A CA2429898 A CA 2429898A CA 2429898 A1 CA2429898 A1 CA 2429898A1
- Authority
- CA
- Canada
- Prior art keywords
- dosage form
- cholesterol
- drug delivery
- delivery device
- lowering agent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4418—Non condensed pyridines; Hydrogenated derivatives thereof having a carbocyclic group directly attached to the heterocyclic ring, e.g. cyproheptadine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Emergency Medicine (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Dermatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Inorganic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Formes galéniques à libération contrôlée sous forme d'implant, dispositifs et procédés servant à administrer un agent abaissant le cholestérol.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US24964400P | 2000-11-16 | 2000-11-16 | |
| US60/249,644 | 2000-11-16 | ||
| PCT/US2001/046714 WO2002067895A2 (fr) | 2000-11-16 | 2001-11-08 | Dispositifs et procedes servant a lutter contre le cholesterol |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CA2429898A1 true CA2429898A1 (fr) | 2002-09-06 |
| CA2429898C CA2429898C (fr) | 2011-02-22 |
Family
ID=22944385
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA2429898A Expired - Fee Related CA2429898C (fr) | 2000-11-16 | 2001-11-08 | Dispositifs et procedes servant a lutter contre le cholesterol |
Country Status (3)
| Country | Link |
|---|---|
| EP (1) | EP1335704A2 (fr) |
| CA (1) | CA2429898C (fr) |
| WO (1) | WO2002067895A2 (fr) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040224903A1 (en) * | 2002-12-19 | 2004-11-11 | Stephen Berry | Stable, non-aqueous, single-phase gels and formulations thereof for delivery from an implantable device |
| US7731947B2 (en) | 2003-11-17 | 2010-06-08 | Intarcia Therapeutics, Inc. | Composition and dosage form comprising an interferon particle formulation and suspending vehicle |
| JP2006521897A (ja) | 2003-03-31 | 2006-09-28 | アルザ・コーポレーション | 内部圧力を放散する手段を備える浸透ポンプ |
| DE602004015755D1 (de) | 2003-03-31 | 2008-09-25 | Alza Corp | Nicht wässrige einphasige visköse vehikel und formulierungen die diese vehikel verwenden |
| US11246913B2 (en) | 2005-02-03 | 2022-02-15 | Intarcia Therapeutics, Inc. | Suspension formulation comprising an insulinotropic peptide |
| WO2006083761A2 (fr) | 2005-02-03 | 2006-08-10 | Alza Corporation | Solutions de solvant/polymere utilisees comme vehicules de suspension |
| US20070027105A1 (en) | 2005-07-26 | 2007-02-01 | Alza Corporation | Peroxide removal from drug delivery vehicle |
| US8852638B2 (en) | 2005-09-30 | 2014-10-07 | Durect Corporation | Sustained release small molecule drug formulation |
| ES2351527T3 (es) | 2006-05-30 | 2011-02-07 | Intarcia Therapeutics, Inc | Modulador de flujo en dos piezas con conducto interno para un sistema osmótico de administración. |
| EP2359808B1 (fr) | 2006-08-09 | 2013-05-22 | Intarcia Therapeutics, Inc | Système de libération osmotique avec ensemble de piston |
| EP2157967B1 (fr) | 2007-04-23 | 2013-01-16 | Intarcia Therapeutics, Inc | Formulations en suspension de peptides insulinotropes et leurs utilisations |
| HUE030789T2 (en) * | 2007-05-18 | 2017-06-28 | Durect Corp | Improved depot formulation |
| BRPI0811319A2 (pt) | 2007-05-25 | 2015-02-10 | Tolmar Therapeutics Inc | Composição fluida, método de formação de uma composição fluida, implante biodegrádavel formado in situ, método de formação de um implante biodegradável in situ, kit, implante e método de trataento |
| CA2726861C (fr) | 2008-02-13 | 2014-05-27 | Intarcia Therapeutics, Inc. | Dispositifs, formulations et methodes d'administration de plusieurs agents benefiques |
| EP3323423B1 (fr) | 2009-09-28 | 2020-06-17 | Intarcia Therapeutics, Inc | Établissement rapide et/ou arrêt rapide d'une administration constante substantielle de médicament |
| SG10201510484YA (en) * | 2010-12-20 | 2016-01-28 | Cormatrix Cardiovascular Inc | A drug eluting patch for the treatment of localized tissue disease or defect |
| US20120208755A1 (en) | 2011-02-16 | 2012-08-16 | Intarcia Therapeutics, Inc. | Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers |
| US11154559B2 (en) | 2011-09-29 | 2021-10-26 | Ethicon Endo-Surgery, Inc. | Methods and compositions of bile acids |
| BR112015022023B1 (pt) | 2013-03-11 | 2022-12-06 | Durect Corporation | Composição de liberação controlada injetável compreendendo transportador líquido de alta viscosidade |
| US20140308352A1 (en) | 2013-03-11 | 2014-10-16 | Zogenix Inc. | Compositions and methods involving polymer, solvent, and high viscosity liquid carrier material |
| US9889085B1 (en) | 2014-09-30 | 2018-02-13 | Intarcia Therapeutics, Inc. | Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c |
| MA44390A (fr) | 2015-06-03 | 2019-01-23 | Intarcia Therapeutics Inc | Systèmes de mise en place et de retrait d'implant |
| SG11201810102SA (en) | 2016-05-16 | 2018-12-28 | Intarcia Therapeutics Inc | Glucagon-receptor selective polypeptides and methods of use thereof |
| USD840030S1 (en) | 2016-06-02 | 2019-02-05 | Intarcia Therapeutics, Inc. | Implant placement guide |
| USD860451S1 (en) | 2016-06-02 | 2019-09-17 | Intarcia Therapeutics, Inc. | Implant removal tool |
| CN110225762A (zh) | 2017-01-03 | 2019-09-10 | 因塔西亚制药公司 | 包括glp-1受体激动剂的连续施用和药物的共同施用的方法 |
| KR20220140711A (ko) | 2020-01-13 | 2022-10-18 | 듀렉트 코퍼레이션 | 불순물이 감소된 지속 방출 약물 전달 시스템 및 관련 방법 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ239370A (en) * | 1990-08-22 | 1994-04-27 | Merck & Co Inc | Bioerodible implantable controlled release dosage form comprising a poly(ortho ester) or a polyacetal with an active agent incorporated into the chain backbone |
| GB9105152D0 (en) * | 1991-03-12 | 1991-04-24 | Glaxo Group Ltd | Chemical compounds |
| BR9912275A (pt) * | 1998-07-20 | 2001-04-17 | Peptech Ltd | Formulação de bioimplante |
-
2001
- 2001-11-08 WO PCT/US2001/046714 patent/WO2002067895A2/fr not_active Application Discontinuation
- 2001-11-08 EP EP01273052A patent/EP1335704A2/fr not_active Ceased
- 2001-11-08 CA CA2429898A patent/CA2429898C/fr not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| WO2002067895A3 (fr) | 2003-04-17 |
| EP1335704A2 (fr) | 2003-08-20 |
| CA2429898C (fr) | 2011-02-22 |
| WO2002067895A2 (fr) | 2002-09-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2429898A1 (fr) | Dispositifs et procedes servant a lutter contre le cholesterol | |
| EP0375156B1 (fr) | Médicaments pour abaisser le niveau du cholestérol sanguin | |
| US6264938B1 (en) | Combination therapy for treating hypercholestrolemia | |
| WO2001068096A2 (fr) | Polytherapie pour la prophylaxie et le traitement d'etats et de troubles hyperlipidemiques | |
| USRE39502E1 (en) | Stable pharmaceutical compositions containing 7-substituted-3,5-dihydroxyheptanoic acids or 7-substituted-3,5-dihydroxyheptenoic acids | |
| CA2491312C (fr) | Film bioeroable pour l'administration de medicaments ophtalmiques | |
| AU2223095A (en) | Effervescent pharmaceutical formulations containing controlled release biodegradable microcapsules | |
| IE970731A1 (en) | Product and method for the treatment of hyperlipidemia | |
| JP2002506812A5 (fr) | ||
| BG105559A (en) | STABLE PHARMACEUTICAL FORMULATION COMPRISING A HMG-CoA REDUCTASE INHIBITOR | |
| AU2001253287A1 (en) | Stable pharmaceutical compositions containing 7-substituted-3,5-dihydroxyheptanoic acids or 7-substituted-3,5-dihydroxyheptenoic acids | |
| US5376383A (en) | Method for enhancing the lowering of plasma-cholesterol levels | |
| WO2001091553A1 (fr) | Tampon composite destine a une administration commandee de medicaments | |
| EP0465096A1 (fr) | Composition pour baisser le niveau du cholésterol du sang | |
| GR990100388A (el) | Φαρμακευτικος συνδυασμος αποτελουμενος απο χωριστες δοσολογικες μορφες σε συσκευασια συμμορφωσης (compliance package) ενος αναστολεα της αναγωγασης του υδροξυ-μεθυλο-γλουταρυλο συνενζυμου α (στατινης, statin) και ενος παραγωγου του φιμπρικου οξεος.... | |
| RU2004127193A (ru) | Лекарственные препараты с активными веществами, понижающими уровень холестерина, с отсроченным высвобождением активного вещества | |
| US20090162420A1 (en) | Matrix-Controlled Transdermal System Comprising Salts of ACE Inhibitor Dicarboxylic Acids | |
| WO2010006451A1 (fr) | Forme galénique contenant une statine | |
| Purushotham et al. | Statin: A boon in periodontal therapy | |
| CA2187153A1 (fr) | Formulations pharmaceutiques effervescentes contenant des microgelules biodegradables a liberation controlee | |
| CA2375378A1 (fr) | Combinaisons antilipemiques comprenant des inhibiteurs de hmg-coa reductase et des carnitines | |
| JP2002525321A5 (ja) | カテーテルによる血管再生を予防または遅らせる医薬組成物の製造のためのコレステロール低下剤の使用 | |
| CA2430760A1 (fr) | Agents hypolipemiants | |
| CA2615941A1 (fr) | Compositions pharmaceutiques a liberation prolongee, stabilisees, comprenant un inhibiteur de l'hmg-coa reductase | |
| WO2000069446A1 (fr) | Polytherapie pour traiter l'hypercholesterolemie |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request | ||
| MKLA | Lapsed | ||
| MKLA | Lapsed |
Effective date: 20121108 |